Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Genomic Health patents

Patents where

Current Assignee

Name

Genomic Health

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9902991 Methods for depleting RNA from nucleic acid samples	Patent 9902991 was granted and assigned to Genomic Health on February, 2018 by the United States Patent and Trademark Office.	Genomic Health	Genomic Health	United States Patent and Trademark Office	9902991	February 27, 2018
‌ US Patent 9005891 Methods for depleting RNA from nucleic acid samples	Patent 9005891 was granted and assigned to Genomic Health on April, 2015 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	9005891	April 14, 2015
‌ US Patent 7081340 Gene expression profiling in biopsied tumor tissues	Patent 7081340 was granted and assigned to Genomic Health on July, 2006 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	7081340	July 25, 2006
‌ US Patent 11551782 Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer	Patent 11551782 was granted and assigned to Genomic Health on January, 2023 by the United States Patent and Trademark Office.	Genomic Health	Genomic Health	United States Patent and Trademark Office	11551782	January 10, 2023
‌ US Patent 7838224 Gene expression profiling in biopsied tumor tissues	Patent 7838224 was granted and assigned to Genomic Health on November, 2010 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	7838224	November 23, 2010
‌ US Patent 7888019 Genes involved estrogen metabolism	Patent 7888019 was granted and assigned to Genomic Health on February, 2011 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	7888019	February 15, 2011
‌ US Patent 8071286 Gene expression profiling in biopsied tumor tissues	Patent 8071286 was granted and assigned to Genomic Health on December, 2011 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	8071286	December 6, 2011
‌ US Patent 8148076 Gene expression profiling of EGFR positive cancer	Patent 8148076 was granted and assigned to Genomic Health on April, 2012 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	8148076	April 3, 2012
‌ US Patent 7767391 Use of intronic RNA to measure gene expression	Patent 7767391 was granted and assigned to Genomic Health on August, 2010 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	7767391	August 3, 2010
‌ US Patent 8725426 Gene expression profile algorithm and test for determining prognosis of prostate cancer	Patent 8725426 was granted and assigned to Genomic Health on May, 2014 by the United States Patent and Trademark Office.	Genomic Health	Genomic Health	United States Patent and Trademark Office	8725426	May 13, 2014
‌ US Patent 7858304 Gene expression profiling in biopsied tumor tissues	Patent 7858304 was granted and assigned to Genomic Health on December, 2010 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	7858304	December 28, 2010
‌ US Patent 8008003 Gene expression profiling of EGFR positive cancer	Patent 8008003 was granted and assigned to Genomic Health on August, 2011 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	8008003	August 30, 2011
‌ US Patent 9551034 Method to use gene expression to determine likelihood of clinical outcome of renal cancer	Patent 9551034 was granted and assigned to Genomic Health on January, 2017 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	9551034	January 24, 2017
‌ US Patent 7056674 Prediction of likelihood of cancer recurrence	Patent 7056674 was granted and assigned to Genomic Health on June, 2006 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	7056674	June 6, 2006
‌ US Patent 11649506 DNA methylation and mutational analysis methods for bladder cancer surveillance	Patent 11649506 was granted and assigned to Genomic Health on May, 2023 by the United States Patent and Trademark Office.	Genomic Health	Genomic Health	United States Patent and Trademark Office	11649506	May 16, 2023
‌ US Patent 8741605 Gene expression markers for breast cancer prognosis	Patent 8741605 was granted and assigned to Genomic Health on June, 2014 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	8741605	June 3, 2014
‌ US Patent 8034565 Gene expression markers for breast cancer prognosis	Patent 8034565 was granted and assigned to Genomic Health on October, 2011 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	8034565	October 11, 2011
‌ US Patent 10260104 Method for using gene expression to determine prognosis of prostate cancer	Patent 10260104 was granted and assigned to Genomic Health on April, 2019 by the United States Patent and Trademark Office.	Genomic Health	Genomic Health	United States Patent and Trademark Office	10260104	April 16, 2019
‌ US Patent 11011252 Gene expression profile algorithm and test for determining prognosis of prostate cancer	Patent 11011252 was granted and assigned to Genomic Health on May, 2021 by the United States Patent and Trademark Office.	Genomic Health	Genomic Health	United States Patent and Trademark Office	11011252	May 18, 2021
‌ US Patent 8206919 Gene expression markers for breast cancer prognosis	Patent 8206919 was granted and assigned to Genomic Health on June, 2012 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	8206919	June 26, 2012
‌ US Patent 8765383 Methods of predicting cancer risk using gene expression in premalignant tissue	Patent 8765383 was granted and assigned to Genomic Health on July, 2014 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	8765383	July 1, 2014
‌ US Patent 8808994 Genes involved in estrogen metabolism	Patent 8808994 was granted and assigned to Genomic Health on August, 2014 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	8808994	August 19, 2014
‌ US Patent 10241114 Gene expression profiling in biopsied tumor tissues	Patent 10241114 was granted and assigned to Genomic Health on March, 2019 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	10241114	March 26, 2019
‌ US Patent 9605318 Gene expression markers for predicting response to chemotherapy	Patent 9605318 was granted and assigned to Genomic Health on March, 2017 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	9605318	March 28, 2017
‌ US Patent 8906625 Genes involved in estrogen metabolism	Patent 8906625 was granted and assigned to Genomic Health on December, 2014 by the United States Patent and Trademark Office.		Genomic Health	United States Patent and Trademark Office	8906625	December 9, 2014

Results per page:

37 results

0 selected

37 results

0 selected